Hemato Oncology Testing Market is Forecasted to Hit USD 23.64 Billion Driven by Cancer Prevalence
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and...
0 Comentários 0 Compartilhamentos 40 Visualizações